Understanding how certain protein structures cause toxicity in Parkinson's disease
Biophysical determination of the underlying cause of α-Syn oligomer toxicity
This study is looking at how certain proteins related to Parkinson's disease can become harmful to brain cells and how different types of fats in our bodies might influence this process, with the hope of finding new ways to help people with Parkinson's.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m Agrilife Research NIH-funded |
| Lab location | 1 site (College Station, UNITED STATES) |
| Project ID | NIH-10909929 on NIH RePORTER |
What this research studies
This research investigates the role of α-synuclein protein structures in the toxicity associated with Parkinson's disease. By examining how different lipid compositions affect the formation of these protein aggregates, the study aims to uncover the relationship between their structure and the resulting toxicity to neurons. Using advanced imaging techniques, researchers will analyze the effects of these aggregates on specific types of neurons in mouse models, providing insights into the mechanisms of neurodegeneration. The findings could lead to a better understanding of Parkinson's disease and potential therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Parkinson's disease or those at risk of developing it due to genetic or environmental factors.
Not a fit: Patients with other neurodegenerative disorders that do not involve α-synuclein aggregation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating Parkinson's disease by targeting the toxic protein aggregates.
How similar studies have performed: Previous research has shown promising results in understanding protein aggregation in neurodegenerative diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
College Station, UNITED STATES
- Texas A&m Agrilife Research — College Station, United States (Active)
Researchers
- Principal investigator: Kurouski, Dmitry — Texas A&m Agrilife Research
- Study coordinator: Kurouski, Dmitry
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.